Program Content


  • (Neo)Adjuvant Tx HER2-Negative EBC
    (Neo)Adjuvant Therapy in HER2-Negative Early Breast Cancer Treatment Selection Tool
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 06, 2023

    View Activity


cover img faculity

Denise A. Yardley

Sarah Cannon Research Institute
Senior Investigator, Breast Cancer Research
Tennessee Oncology, PLLC
Nashville, Tennessee

cover img faculity

Tanya Gupta, MD

Clinical Assistant Professor
Breast Oncology
Stanford Healthcare
Palo Alto, California

cover img faculity

Kevin Kalinsky, MD, MS

Professor of Medicine
Director, Glenn Family Breast Center
Winship Cancer Institute
Emory University
Atlanta, Georgia

cover img faculity

Laura M. Spring, MD

Breast Medical Oncologist
Mass General Cancer Center
Harvard Medical School
Boston, Massachusetts

cover img faculity

Tiffany Traina, MD

Associate Professor of Medicine
Weill Cornell Medical College
Vice Chair, Oncology Care
Department of Medicine/Breast Medicine Service
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

ProCE Banner


Supported by educational grants from AstraZeneca and Merck Sharp & Dohme LLC.


Merck Sharp & Dohme, LLC


Smart Patients

ProCE Banner